Background: Hepatitis C virus infection is worldwide health issue. Aims & Objectives: To compare and correlate the mean levels of biochemical parameters i.e. total bilirubin, ALT, AST, a-GST and PCR quantitative at day zero and one month after the start of the treatment with Interferon alpha-2b and ribavirin. Materials & methods: The study consists of 40 patients with normal liver and clinical evidence of compensatory liver disease (early stage cirrhosis) on ultrasound examination. Before the start of IFN alpha-2b and ribavirin treatment, at zero day, all of the 40 patients were HCV- RNA positive. One month after the start of IFN alpha-2b and ribavirin treatment (Ribavirin 500mg B.D and IFN alpha-2b 4.5 mega units,(3times per week for 6 months) these 40 patients were again tested. On the basis of the presence of HCV-RNA virus, they were classified into two groups (A&B). Results: After treatment, viral load was significantly reduced in group A (n=31), and significantly reduced in patients of group B (n=9). ALT and AST levels were reduced significantly in patients of Group A (n=31) and insignificantly reduced in patients of group B after treatment. After treatment, Alpha-GST level was significantly elevated among patients of Group A (n=31) who remained HCV-RNA positive and significantly reduced in HCVRNA negative patients in group B (n=9) Conclusion: In hepatic insults, a-GST levels show an early rise in serum. So, a-GST level is a sensitive method for evaluation of hepatic insults without ALT elevation.